Advertisement

Esophagus

, Volume 13, Issue 4, pp 343–350 | Cite as

Postoperative infectious complications-driven recurrence after radical resection for esophageal cancer

  • Takashi Murakami
  • Chikara KunisakiEmail author
  • Shinichi Hasegawa
  • Jun Kimura
  • Ryo Takagawa
  • Takashi Kosaka
  • Hidetaka A. Ono
  • Hirochika Makino
  • Hirotoshi Akiyama
  • Itaru Endo
Original Article
  • 151 Downloads

Abstract

Background

Few reports have reported the long-term outcome of esophageal cancer patients suffering from postoperative infectious complications. Here, we investigated the impact of postoperative infectious complications in patients who had undergone curative resection for esophageal cancer.

Methods

The study population comprised 97 patients who underwent radical resection for esophageal cancer with curative intent between 2001 and 2008. Postoperative infectious complications were defined as surgical site infections and pneumonia. We compared clinical features, tumor histology, recurrence, and overall survival between patients with postoperative infections and those who did not.

Results

Of the 97 patients studied, 37 had postoperative infectious complications. The disease-free and overall survival rates of the entire cohort did not significantly differ between patients with and without postoperative infectious complications. Univariate analysis revealed that among patients with stage III esophageal cancer, those with postoperative infectious complications demonstrated significantly shorter disease-free survival than those without. Multivariate analysis demonstrated that postoperative infectious complications were independent prognostic indicators for disease-free survival of stage III esophageal cancer patients.

Conclusions

Our findings suggest that postoperative infectious complications in stage III esophageal cancer patients have a negative impact on disease-free survival.

Keywords

Esophageal cancer Postoperative complications Infection Disease-free survival 

Notes

Acknowledgments

We would like to thank a statistician, Dr. Mari S. Oba, for her analysis and interpretation of the data, and Dr. Jonathan C. DeLong for his English proofreading in this manuscript. We are also grateful to all the surgeons for their important contribution to treating patients and collecting clinical data in the Yokohama City University.

Compliance with ethical standards

Ethical Statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. 1.
    Stein HJ, Siewert JR. Improved prognosis of resected esophageal cancer. World J Surg. 2004;28:520–5.CrossRefPubMedGoogle Scholar
  2. 2.
    Tsujimoto H, Ichikura T, Ono S, et al. Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann Surg Oncol. 2009;16:311–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Nowacki MP, Szymendera JJ. The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum. 1983;26:263–8.CrossRefPubMedGoogle Scholar
  4. 4.
    DerHagopian RP, Sugarbaker EV, Ketcham A. Inflammatory oncotaxis. JAMA. 1978;240:374–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Wang D, DuBois RN. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis. 2015;36:1085–93.CrossRefPubMedGoogle Scholar
  6. 6.
    Hirai T, Yamashita Y, Mukaida H, et al. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28:576–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.CrossRefPubMedGoogle Scholar
  8. 8.
    Lagarde SM, de Boer JD, ten Kate FJ, et al. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008;247:71–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Kanda M, Fujii T, Kodera Y, et al. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98:268–74.CrossRefPubMedGoogle Scholar
  10. 10.
    Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMedGoogle Scholar
  11. 11.
    Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.CrossRefPubMedGoogle Scholar
  14. 14.
    Zarogoulidis P, Lampaki S, Yarmus L, et al. Interleukin-7 and interleukin-15 for cancer. J Cancer. 2014;5:765–73.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rivas-Fuentes S, Salgado-Aguayo A, Pertuz Belloso S, et al. Role of chemokines in non-small cell lung cancer: angiogenesis and inflammation. J Cancer. 2015;6:938–52.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Cavassani KA, Carson WF, Moreira AP, et al. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood. 2010;115:4403–11.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Ray A, Chakraborty K, Ray P. Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation. Front Cell Infect Microbiol. 2013;3:52.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg. 2009;92:1150–4.CrossRefGoogle Scholar
  20. 20.
    Law WL, Choi HK, Lee YM, et al. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol. 2007;14:2559–66.CrossRefPubMedGoogle Scholar
  21. 21.
    Han HS, Cho JY, Yoon YS, et al. Preoperative inflammation is a prognostic factor for gallbladder carcinoma. Br J Surg. 2011;98:111–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Tingstedt B, Johansson P, Andersson B, et al. Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol. 2007;42:754–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Pierce BL, Ballard-Barbash R, Bernstein L, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009;27:3437–44.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Khuri SF, Henderson WG, DePalma RG, et al. Participants in the VA National Surgical Quality Improvement Program: determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326–43.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Xia BT, Rosato EL, Chojnacki KA, et al. Major perioperative morbidity does not affect long-term survival in patients undergoing esophagectomy for cancer of the esophagus or gastroesophageal junction. World J Surg. 2013;37:408–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Tokunaga M, Tanizawa Y, Bando E, et al. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2013;20:1575–83.CrossRefPubMedGoogle Scholar
  27. 27.
    Markar S, Gronnier C, Duhamel A, et al. The impact of severe anastomotic leak on long-term survival and cancer recurrence after surgical resection for esophageal malignancy. Ann Surg. 2015;262:972–80.CrossRefPubMedGoogle Scholar
  28. 28.
    Mirnezami A, Mirnezami R, Chandrakumaran K, et al. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253:890–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Hayashi T, Yoshikawa T, Aoyama T, et al. Impact of infectious complications on gastric cancer recurrence. Gastric Cancer. 2015;18:368–74.CrossRefPubMedGoogle Scholar
  30. 30.
    Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15:425–30.CrossRefPubMedGoogle Scholar
  31. 31.
    Jiang Tao, Zhang Xianjie, Ding Jing, et al. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation. Int J Clin Exp Pathol. 2015;8:13945–56.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Kunisaki C, Makino H, Takagawa R, et al. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg. 2008;12:802–10.CrossRefPubMedGoogle Scholar
  33. 33.
    Miyata H, Yamasaki M, Kurokawa Y, et al. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18:3353–61.CrossRefPubMedGoogle Scholar
  34. 34.
    Parry K, Visser E, van Rossum PS, et al. Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent. Ann Surg Oncol. 2015;22:S1292–300.CrossRefPubMedGoogle Scholar
  35. 35.
    Ajani JA, D’Amico TA, Almhanna K, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw. 2015;13:194–227.PubMedGoogle Scholar

Copyright information

© The Japan Esophageal Society and Springer Japan 2016

Authors and Affiliations

  • Takashi Murakami
    • 1
    • 2
  • Chikara Kunisaki
    • 1
    Email author
  • Shinichi Hasegawa
    • 1
  • Jun Kimura
    • 1
  • Ryo Takagawa
    • 1
  • Takashi Kosaka
    • 2
  • Hidetaka A. Ono
    • 1
  • Hirochika Makino
    • 1
  • Hirotoshi Akiyama
    • 2
  • Itaru Endo
    • 2
  1. 1.Department of Surgery, Gastroenterological CenterYokohama City UniversityYokohamaJapan
  2. 2.Department of Gastroenterological Surgery, Graduate School of MedicineYokohama City UniversityYokohamaJapan

Personalised recommendations